Cas No.: | 870823-12-4 |
Chemical Name: | .beta.-Alanine, N-[4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxy-2-naphthalenyl)-1H-pyrazol-1-yl]ethyl]benzoyl]- |
Synonyms: | MK0893;MK 0893 |
SMILES: | ClC1=CC(Cl)=CC(C2C=C(C3C=CC4C(=CC=C(OC)C=4)C=3)N(C(C3C=CC(C(NCCC(O)=O)=O)=CC=3)C)N=2)=C1 |
Formula: | C32H27Cl2N3O4 |
M.Wt: | 588.4805 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A potent, selective, reversible and competitive antagonist of glucagon receptor with high binding affinity (IC(=50=6.6 nM) and functional cAMP activity (IC50=15.7 nM); displays selectivity for glucagon receptor relative to other family B GPCRs, IC50 of 1020 nM for GIPR, 9200 nM for PAC1, and >10000 nM for GLP-1R, VPAC1, and VPAC2; blunts glucagon-induced glucose elevation in hGCGR mice and rhesus monkeys, also lowers ambient glucose levels in both acute and chronic mouse models.DiabetesPhase 2 Discontinued |